| Financial Year |
March 31 2023 |
| Monetary Funds |
91,995,201.38 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
13,157,027.90 |
| Accounts Receivable |
326,381,040.24 |
| Advances to Suppliers |
14,740,895.45 |
| Other Receivables |
12,671,110.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
312,967,625.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,001,387.49 |
| Total Current Assets |
814,904,349.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
712,790,359.76 |
| Under-construction Projects |
20,955,317.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
79,755,638.82 |
| R&D expenses |
-- |
| Goodwill |
58,231,132.55 |
| Long-Term Deferred and Prepaid Expenses |
1,896,129.22 |
| Deferred Income Tax Assets |
19,874,079.75 |
| Other Non-Current Assets |
39,995,260.48 |
| Sub-Total of Non-Current Assets |
933,497,918.24 |
| Total Assets |
1,748,402,267.59 |
| Short-Term Loans |
180,198,361.09 |
| Trading Financial liabilities |
-- |
| Notes Payable |
21,900,000.00 |
| Accounts Payable |
151,288,994.19 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,507,999.16 |
| Taxes Payable |
4,285,158.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,156,763.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
13,282,102.84 |
| Sub-Total of Current Liabilities |
396,794,728.49 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,542,106.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
66,133,649.31 |
| Total Liabilities |
462,928,377.80 |
| Paid-In Capital(Or Share Stock) |
247,585,404.00 |
| Capital Surplus |
732,900,577.72 |
| Surplus Reserve |
60,988,194.75 |
| LESS:Treasury Stock |
11,059,200.00 |
| Undistributed Profits |
255,037,448.83 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,285,473,889.79 |
| Owner's Equity（Stockholder's Equity） |
1,285,473,889.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,748,402,267.59 |
